Site identification

The Context
We are fully aware that the ultimate success of a study is linked to the selection of appropriate, qualified and productive sites, which is why we put a particular emphasis on site identification.
We can take full responsibility for the initial selection of sites or combine your own database with our lists.
Our process includes a detailed evaluation of the following aspects:
- Past history of clinical study/research involvement
- Investigator competencies and experience in clinical trials and health research studies
- Availability of co-investigators and research team
- Team workload
- Ongoing competing projects
- Training of site staff in ICH-GCP, other regulatory requirements and local procedures - Site facilities and equipment
- Recruitment potential

Wherever possible we also maintain a list of backup sites in an operational state on stand-by that can be quickly initiated if additional sites or site replacements are required.

Our solutions:
 Early Stage Clinical Trials / Phase II and III Clinical Trials
 Late Phase Clinical Trials / Post Marketing Safety Studies
 Product Value and Effectiveness in Real-world
 Public Health and Social Science Research

Why Africa

Africa offers an increasing number of experienced researchers through networks of excellence implemented ...

Read more


At Pharmalys we believe in the value of partnership, sharing knowledge and establishing synergies in order to develop innovative solutions ...

Read more

Become an Investigator

You can make a difference to a noble cause by getting involved in health related studies

Read more


Pharmalys Ltd UK
Tel: +44 208 0909 620

Pharmalys SARL Senegal
Tel: +221 33 825 42 43

Read more
Go to top